This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $512,551
Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial
CIHR · 2023 · Principal investigator
Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial
Principal investigators: Husain, Shahid; Belga, Sara; Daneman, Nick; Dufresne, Simon F; Haider, Shariq; Kabbani, Dima; Pérez-Cortés Villalobos, Armelle; Shalhoub, Sarah; Stern, Anat
Keywords: Acute Leukemia; Allogeneic Hematopoietic Stem Cell Transplant; Antibiotic Stewardship; Febrile Neutropenia
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.